We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

80 hedge funds and large institutions have $319M invested in Syneron Medical Ltd in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,404% more call options, than puts

Call options by funds: $376K | Put options by funds: $25K

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

27% more capital invested

Capital invested by funds: $252M → $319M (+$67M)

18% more funds holding

Funds holding: 6880 (+12)

Holders
80
Holders Change
+12
Holders Change %
+17.65%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
21
Increased
27
Reduced
11
Closed
9
Calls
$376K
Puts
$25K
Net Calls
+$351K
Net Calls Change
+$314K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
$304K -$679K -61,340 -71%
GI
52
GAMCO Investors
Connecticut
$297K
Nomura Holdings
53
Nomura Holdings
Japan
$294K +$133K +11,982 +99%
Bank of America
54
Bank of America
North Carolina
$288K +$248K +22,376 +2,492%
CS
55
Credit Suisse
Switzerland
$271K +$242K +21,854 New
ARTA
56
A.R.T. Advisors
New York
$235K +$87.3K +7,887 +71%
GCP
57
GSA Capital Partners
United Kingdom
$233K +$208K +18,800 New
OAM
58
Oberweis Asset Management
Illinois
$220K +$197K +17,800 New
KeyBank National Association
59
KeyBank National Association
Ohio
$218K -$49.1K -4,437 -20%
Invesco
60
Invesco
Georgia
$214K +$11.1K +1,000 +6%
BG
61
BlackRock Group
United Kingdom
$205K
GF
62
Gabelli Funds
New York
$173K
RC
63
RBF Capital
California
$161K +$25.9K +2,339 +22%
Goldman Sachs
64
Goldman Sachs
New York
$159K +$142K +12,812 New
State Street
65
State Street
Massachusetts
$145K
Geode Capital Management
66
Geode Capital Management
Massachusetts
$139K +$2.71K +245 +2%
TC
67
TFS Capital
Pennsylvania
$134K +$2.51K +227 +2%
BIT
68
BlackRock Institutional Trust
California
$125K +$51.1K +4,618 +85%
PCM
69
Prelude Capital Management
New York
$45K +$40K +3,616 New
Group One Trading
70
Group One Trading
Illinois
$28K +$17.7K +1,600 +246%
BNP Paribas Financial Markets
71
BNP Paribas Financial Markets
France
$10.6K +$5K +452 +112%
NFG
72
Next Financial Group
Texas
$7K
DADC
73
D.A. Davidson & Co
Montana
$6K
Creative Planning
74
Creative Planning
Kansas
$5K
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$5K

ELOS Hedge Fund Activity: Q1 2015 in Review

80 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2015, worth a combined $319M — up 27% from $252M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ELOS positions and 9 closed out — a net gain of 12 holders — while 27 added to existing stakes and 11 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $9.1M. The largest seller was Baupost Group, exiting entirely with an estimated $22.5M sold.

  • 80 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2015, up from 68 in Q4 2014.
  • Funds reported $319M of Syneron Medical Ltd stock for Q1 2015, up 27% quarter-over-quarter.
  • 21 funds opened new Syneron Medical Ltd positions in Q1 2015 and 9 closed out, a net change of +12 holders.
  • The largest Syneron Medical Ltd buyer in Q1 2015 was JP Morgan Chase, an estimated $9.1M added.
  • The largest Syneron Medical Ltd seller in Q1 2015 was Baupost Group, an estimated $22.5M sold.

Based on aggregated 13F filings for Q1 2015.